A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

Completed

Plain-English translation of NCT04458857 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(89 sites)

United States

Teva Investigational Site 14281, Little Rock, Arkansas

Teva Investigational Site 14253, Banning, California

Teva Investigational Site 14370, Loma Linda, California

Teva Investigational Site 14322, Los Angeles, California

Teva Investigational Site 14361, Sacramento, California